Arvind S. Negi
Impact in
- Drug Discovery top 0.01%
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds
Papers in
- Toxicology 11
- Bioactive Compounds and Antitumor Agents 11
-
- Tannin, Tannase and Anticancer Activities 6
- Co-authors
- Suaib LuqmanKaruna ShankerDebabrata ChandaS. P. S. KhanujaFeroz KhanJ. Kotesh KumarMahendra P. DarokarJayanta Sarkar
- Journals
- Bioorganic & Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)European Journal of Medicinal Chemistry (5 papers)Bioorganic Chemistry (4 papers)European Journal of Pharmacology (4 papers)
- Partner nations
- IndiaItalyUnited States
In The Last Decade
Arvind S. Negi
73 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 120
- Drug Discovery 85
- Pharmacology 412
- Toxicology 152
- Organic Chemistry 1.0k
- Complementary and alternative medicine 277
Countries citing papers authored by Arvind S. Negi
This map shows the geographic impact of Arvind S. Negi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind S. Negi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind S. Negi more than expected).
Fields of papers citing papers by Arvind S. Negi
This network shows the impact of papers produced by Arvind S. Negi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind S. Negi. The network helps show where Arvind S. Negi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arvind S. Negi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 22 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 136 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 62 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 11 | |
| 14 | 2015 | 8 | |
| 15 | 2014 | 61 | |
| 16 | 2014 | 55 | |
| 17 | 2013 | 32 | |
| 18 | 2012 | 6 | |
| 19 | 2012 | 55 | |
| 20 | 2010 | 13 |
About Arvind S. Negi
Arvind S. Negi is a scholar working on Toxicology, Applied Microbiology and Biotechnology, Organic Chemistry, Pharmacology and Molecular Medicine, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Synthesis and biological activity (29 papers), Bioactive Compounds and Antitumor Agents (11 papers), Microbial Natural Products and Biosynthesis (8 papers), Cancer therapeutics and mechanisms (7 papers), Synthesis and Biological Evaluation (6 papers), Computational Drug Discovery Methods (6 papers), Cancer Treatment and Pharmacology (6 papers) and Tannin, Tannase and Anticancer Activities (6 papers). The work is most often cited by research in Drug Discovery (85 citations), Pharmacology (412 citations), Toxicology (152 citations), Organic Chemistry (1.0k citations) and Complementary and alternative medicine (277 citations). Arvind S. Negi has collaborated with scholars based in India, Italy and United States. Frequent co-authors include Suaib Luqman, Karuna Shanker, Debabrata Chanda, S. P. S. Khanuja, Feroz Khan, J. Kotesh Kumar, Mahendra P. Darokar, Jayanta Sarkar, Dharmendra Saikia and Arjun Singh. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Bioorganic Chemistry and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.